Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantationWei‐Feng Qu, Ying–Hong Shi, Yuan Fang et al.|Hepatology International|2023Cited by 58
Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapyJun Gao, Ying–Hong Shi, Yuan Fang et al.|Oncogene|2023Cited by 44
Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinomaTianhao Chu, Ying–Hong Shi, Gui‐Qi Zhu et al.|Nature Communications|2025Cited by 31
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinomaWeiren Liu, Ying–Hong Shi, Huqiang Wang et al.|癌症：英文版|2023Cited by 17
Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantationJiafeng Chen, Ying–Hong Shi, Yuan Fang et al.|Hepatology International|2025Cited by 7